• Latest Posts

M&As: what’s up with the ADC buying spree?

Weekly Roundup 10 Nov 2023

Korro Bio and Frequency’s merger; Lexeo’s $100 million IPO; Gate Biosciences new class of drugs

In Depth 27 Oct 2023

Big pharma monopolies: major antitrust cases over the past decade

Biogen acquiring Reata Pharmaceuticals for $7.3B

Sosei Heptares hails ‘transformational’ acquisition

ADVERTISEMENT

Korro Bio and Frequency Therapeutics to merge

Boost for Charcot-Marie-Tooth patients as Novartis acquires DTx Pharma

Lilly boosts obesity portfolio with Versanis Bio acquisition

Novartis acquires Chinook Therapeutics for $3.2B

Podcast 9 Jun 2023

Beyond Biotech podcast 49

Lonza boosts ADC portfolio with Synaffix acquisition

ADVERTISEMENT